Global Leuprolide Acetate Market 2020 - Research Report, Demand, Price, By Application, Region and Forecast to 2026

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 97   |    Publisher : e-Market Research

This report studies the global market size of Leuprolide Acetate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Leuprolide Acetate in these regions.
This research report categorizes the global Leuprolide Acetate market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
In 2017, the global Leuprolide Acetate market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Leuprolide Acetate market based on company, product type, application and key regions.

The various contributors involved in the value chain of Leuprolide Acetate include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Leuprolide Acetate include
    Tolmar Pharmaceuticals
    Varian Pharmed
    Avenit
    Takeda Pharmaceutical
    Sun Pharmaceutical Industries
    Livzon Pharmaceutical
    Beijing Biote Pharmaceutical
    Soho-YImIng
    AbbVie
    Sanofi
    Astellas Pharma
    Abbott
    Merck
    Pfizer

Market Size Split by Type
    Intramuscular
    Subcutaneous
Market Size Split by Application
    Prostate Cancer
    Precocious
    Uterine Fibroid
    Others

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Leuprolide Acetate market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Leuprolide Acetate market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Leuprolide Acetate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Leuprolide Acetate with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Leuprolide Acetate submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Leuprolide Acetate are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Leuprolide Acetate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Leuprolide Acetate Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Leuprolide Acetate Market Size Growth Rate by Type
        1.4.2 Intramuscular
        1.4.3 Subcutaneous
    1.5 Market by Application
        1.5.1 Global Leuprolide Acetate Market Size Growth Rate by Application
        1.5.2 Prostate Cancer
        1.5.3 Precocious
        1.5.4 Uterine Fibroid
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Leuprolide Acetate Market Size
        2.1.1 Global Leuprolide Acetate Revenue 2016-2025
        2.1.2 Global Leuprolide Acetate Sales 2016-2025
    2.2 Leuprolide Acetate Growth Rate by Regions
        2.2.1 Global Leuprolide Acetate Sales by Regions
        2.2.2 Global Leuprolide Acetate Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Leuprolide Acetate Sales by Manufacturers
        3.1.1 Leuprolide Acetate Sales by Manufacturers
        3.1.2 Leuprolide Acetate Sales Market Share by Manufacturers
        3.1.3 Global Leuprolide Acetate Market Concentration Ratio (CR5 and HHI)
    3.2 Leuprolide Acetate Revenue by Manufacturers
        3.2.1 Leuprolide Acetate Revenue by Manufacturers (2016-2018)
        3.2.2 Leuprolide Acetate Revenue Share by Manufacturers (2016-2018)
    3.3 Leuprolide Acetate Price by Manufacturers
    3.4 Leuprolide Acetate Manufacturing Base Distribution, Product Types
        3.4.1 Leuprolide Acetate Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Leuprolide Acetate Product Category
        3.4.3 Date of International Manufacturers Enter into Leuprolide Acetate  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Leuprolide Acetate Sales by Type
    4.2 Global Leuprolide Acetate Revenue by Type
    4.3 Leuprolide Acetate Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Leuprolide Acetate Breakdown Data by Application

6 North America
    6.1 North America Leuprolide Acetate by Countries
        6.1.1 North America Leuprolide Acetate Sales by Countries
        6.1.2 North America Leuprolide Acetate Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Leuprolide Acetate by Type
    6.3 North America Leuprolide Acetate by Application
    6.4 North America Leuprolide Acetate by Company

7 Europe
    7.1 Europe Leuprolide Acetate by Countries
        7.1.1 Europe Leuprolide Acetate Sales by Countries
        7.1.2 Europe Leuprolide Acetate Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Leuprolide Acetate by Type
    7.3 Europe Leuprolide Acetate by Application
    7.4 Europe Leuprolide Acetate by Company

8 Asia Pacific
    8.1 Asia Pacific Leuprolide Acetate by Countries
        8.1.1 Asia Pacific Leuprolide Acetate Sales by Countries
        8.1.2 Asia Pacific Leuprolide Acetate Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Leuprolide Acetate by Type
    8.3 Asia Pacific Leuprolide Acetate by Application
    8.4 Asia Pacific Leuprolide Acetate by Company

9 Central & South America
    9.1 Central & South America Leuprolide Acetate by Countries
        9.1.1 Central & South America Leuprolide Acetate Sales by Countries
        9.1.2 Central & South America Leuprolide Acetate Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Leuprolide Acetate by Type
    9.3 Central & South America Leuprolide Acetate by Application
    9.4 Central & South America Leuprolide Acetate by Company

10 Middle East and Africa
    10.1 Middle East and Africa Leuprolide Acetate by Countries
        10.1.1 Middle East and Africa Leuprolide Acetate Sales by Countries
        10.1.2 Middle East and Africa Leuprolide Acetate Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Leuprolide Acetate by Type
    10.3 Middle East and Africa Leuprolide Acetate by Application
    10.4 Middle East and Africa Leuprolide Acetate by Company

11 Company Profiles
    11.1 Tolmar Pharmaceuticals
        11.1.1 Tolmar Pharmaceuticals Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.1.4 Leuprolide Acetate Product Description
        11.1.5 Recent Development
    11.2 Varian Pharmed
        11.2.1 Varian Pharmed Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.2.4 Leuprolide Acetate Product Description
        11.2.5 Recent Development
    11.3 Avenit
        11.3.1 Avenit Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.3.4 Leuprolide Acetate Product Description
        11.3.5 Recent Development
    11.4 Takeda Pharmaceutical
        11.4.1 Takeda Pharmaceutical Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.4.4 Leuprolide Acetate Product Description
        11.4.5 Recent Development
    11.5 Sun Pharmaceutical Industries
        11.5.1 Sun Pharmaceutical Industries Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.5.4 Leuprolide Acetate Product Description
        11.5.5 Recent Development
    11.6 Livzon Pharmaceutical
        11.6.1 Livzon Pharmaceutical Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.6.4 Leuprolide Acetate Product Description
        11.6.5 Recent Development
    11.7 Beijing Biote Pharmaceutical
        11.7.1 Beijing Biote Pharmaceutical Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.7.4 Leuprolide Acetate Product Description
        11.7.5 Recent Development
    11.8 Soho-YImIng
        11.8.1 Soho-YImIng Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.8.4 Leuprolide Acetate Product Description
        11.8.5 Recent Development
    11.9 AbbVie
        11.9.1 AbbVie Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.9.4 Leuprolide Acetate Product Description
        11.9.5 Recent Development
    11.10 Sanofi
        11.10.1 Sanofi Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Leuprolide Acetate
        11.10.4 Leuprolide Acetate Product Description
        11.10.5 Recent Development
    11.11 Astellas Pharma
    11.12 Abbott
    11.13 Merck
    11.14 Pfizer

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Leuprolide Acetate Raw Material
        13.1.2 Leuprolide Acetate Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Leuprolide Acetate
    Figure Global Leuprolide Acetate Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Leuprolide Acetate Production Market Share by Types (Product Category) in 2017
    Figure Intramuscular Product Picture
    Table Major Manufacturers of Intramuscular
    Figure Subcutaneous Product Picture
    Table Major Manufacturers of Subcutaneous
    Table Global Leuprolide Acetate Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Prostate Cancer
    Figure Precocious
    Figure Uterine Fibroid
    Figure Others
    Figure Leuprolide Acetate Report Years Considered
    Figure Global Leuprolide Acetate Market Size 2016-2025 (Million US$)
    Figure Global Leuprolide Acetate Sales 2016-2025 (K Units)
    Table Global Leuprolide Acetate Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Leuprolide Acetate Sales by Regions 2016-2025 (K Units)
    Table Global Leuprolide Acetate Sales Market Share by Regions 2016-2025
    Figure Global Leuprolide Acetate Sales Market Share by Regions 2016-2025
    Figure 2017 Global Leuprolide Acetate Sales Market Share by Regions
    Table Global Leuprolide Acetate Revenue by Regions 2016-2025 (Million US$)
    Table Global Leuprolide Acetate Revenue Market Share by Regions 2016-2025
    Figure Global Leuprolide Acetate Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Leuprolide Acetate Revenue Market Share by Regions
    Table Global Leuprolide Acetate Sales by Manufacturers (2016-2018) (K Units)
    Table Global Leuprolide Acetate Sales Share by Manufacturers (2016-2018)
    Figure Global Leuprolide Acetate Sales Share by Manufacturers in 2017
    Table Leuprolide Acetate Revenue by Manufacturers (2016-2018) (Million US$)
    Table Leuprolide Acetate Revenue Share by Manufacturers (2016-2018)
    Figure Leuprolide Acetate Value Share by Manufacturers in 2017
    Table Global Leuprolide Acetate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Leuprolide Acetate Price (2016-2018) (USD/Unit)
    Table Leuprolide Acetate Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Leuprolide Acetate Product Category
    Table Date of International Manufacturers Enter into Leuprolide Acetate Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Leuprolide Acetate Sales by Type (2016-2025) (K Units)
    Table Global Leuprolide Acetate Sales Share by Type (2016-2025)
    Figure Global Leuprolide Acetate Sales Market Share by Type (2016-2025)
    Figure Global Leuprolide Acetate Sales Market Share by Type in 2017
    Table Global Leuprolide Acetate Revenue by Type (2016-2025) (Million US$)
    Table Global Leuprolide Acetate Revenue Share by Type (2016-2025)
    Figure Global Leuprolide Acetate Revenue Market Share by Type (2016-2025)
    Figure Global Leuprolide Acetate Revenue Market Share by Type in 2017
    Table Leuprolide Acetate Price by Type 2013-2018 (USD/Unit)
    Table Global Leuprolide Acetate Sales by Application (2016-2025) (K Units)
    Table Global Leuprolide Acetate Sales Share by Application (2016-2025)
    Figure Global Sales Leuprolide Acetate Market Share by Application (2016-2025)
    Figure Global Sales Leuprolide Acetate Market Share by Application (2016-2025)
    Figure North America Leuprolide Acetate Sales Growth Rate 2016-2025 (K Units)
    Figure North America Leuprolide Acetate Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Leuprolide Acetate Sales by Countries (2016-2025) (K Units)
    Table North America Leuprolide Acetate Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Leuprolide Acetate Sales Market Share by Countries
    Table North America Leuprolide Acetate Revenue by Countries (2016-2025) (Million US$)
    Table North America Leuprolide Acetate Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Leuprolide Acetate Revenue Market Share by Countries
    Figure United States Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure United States Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Leuprolide Acetate Sales by Type (2016-2025) (K Units)
    Table North America Leuprolide Acetate Sales Market Share by Type (2016-2025)
    Figure 2017 North America Leuprolide Acetate Market Share by Type
    Table North America Leuprolide Acetate Sales by Application (2016-2025) (K Units)
    Table North America Leuprolide Acetate Sales Market Share by Application (2016-2025)
    Figure 2017 North America Leuprolide Acetate Market Share by Application
    Table North America Leuprolide Acetate Sales by Company (2016-2018) (K Units)
    Table North America Leuprolide Acetate Sales Market Share by Company (2016-2018)
    Figure North America Leuprolide Acetate Sales Market Share by Company in 2017
    Figure Europe Leuprolide Acetate Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Leuprolide Acetate Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Leuprolide Acetate Sales by Countries (2016-2025) (K Units)
    Table Europe Leuprolide Acetate Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Leuprolide Acetate Sales Market Share by Countries
    Table Europe Leuprolide Acetate Revenue by Countries (2016-2025) (Million US$)
    Table Europe Leuprolide Acetate Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Leuprolide Acetate Revenue Market Share by Countries
    Figure Germany Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Leuprolide Acetate Revenue Growth Rate (2016-2025) (K Units)
    Figure France Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure France Leuprolide Acetate Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure UK Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Leuprolide Acetate Sales by Type (2016-2025) (K Units)
    Table Europe Leuprolide Acetate Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Leuprolide Acetate Market Share by Type
    Table Europe Leuprolide Acetate Sales by Application (2016-2025) (K Units)
    Table Europe Leuprolide Acetate Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Leuprolide Acetate Market Share by Application
    Table Europe Leuprolide Acetate Sales by Company (2016-2018) (K Units)
    Table Europe Leuprolide Acetate Sales Market Share by Company (2016-2018)
    Figure Europe Leuprolide Acetate Sales Market Share by Company in 2017
    Figure Asia Pacific Leuprolide Acetate Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Leuprolide Acetate Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Leuprolide Acetate Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Leuprolide Acetate Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Leuprolide Acetate Sales Market Share by Countries
    Table Asia Pacific Leuprolide Acetate Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Leuprolide Acetate Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Leuprolide Acetate Revenue Market Share by Countries
    Figure China Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure China Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure India Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Leuprolide Acetate Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Leuprolide Acetate Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Leuprolide Acetate Market Share by Type
    Table Asia Pacific Leuprolide Acetate Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Leuprolide Acetate Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Leuprolide Acetate Market Share by Application
    Table Asia Pacific Leuprolide Acetate Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Leuprolide Acetate Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Leuprolide Acetate Sales Market Share by Company in 2017
    Figure Central & South America Leuprolide Acetate Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Leuprolide Acetate Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Leuprolide Acetate Sales by Countries (2016-2025) (K Units)
    Table Central & South America Leuprolide Acetate Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Leuprolide Acetate Sales Market Share by Countries
    Table Central & South America Leuprolide Acetate Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Leuprolide Acetate Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Leuprolide Acetate Revenue Market Share by Countries
    Figure Brazil Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Leuprolide Acetate Sales by Type (2016-2025) (K Units)
    Table Central & South America Leuprolide Acetate Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Leuprolide Acetate Market Share by Type
    Table Central & South America Leuprolide Acetate Sales by Application (2016-2025) (K Units)
    Table Central & South America Leuprolide Acetate Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Leuprolide Acetate Market Share by Application
    Table Central & South America Leuprolide Acetate Sales by Company (2016-2018) (K Units)
    Table Central & South America Leuprolide Acetate Sales Market Share by Company (2016-2018)
    Figure Central & South America Leuprolide Acetate Sales Market Share by Company in 2017
    Figure Middle East and Africa Leuprolide Acetate Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Leuprolide Acetate Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Leuprolide Acetate Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Leuprolide Acetate Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Leuprolide Acetate Sales Market Share by Countries
    Table Middle East and Africa Leuprolide Acetate Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Leuprolide Acetate Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Leuprolide Acetate Revenue Market Share by Countries
    Figure GCC Countries Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Leuprolide Acetate Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Leuprolide Acetate Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Leuprolide Acetate Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Leuprolide Acetate Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Leuprolide Acetate Market Share by Type
    Table Middle East and Africa Leuprolide Acetate Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Leuprolide Acetate Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Leuprolide Acetate Market Share by Application
    Table Middle East and Africa Leuprolide Acetate Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Leuprolide Acetate Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Leuprolide Acetate Sales Market Share by Company in 2017
    Table Tolmar Pharmaceuticals Company Details
    Table Tolmar Pharmaceuticals Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Tolmar Pharmaceuticals Recent Development
    Table Varian Pharmed Company Details
    Table Varian Pharmed Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Varian Pharmed Recent Development
    Table Avenit Company Details
    Table Avenit Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Avenit Recent Development
    Table Takeda Pharmaceutical Company Details
    Table Takeda Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Takeda Pharmaceutical Recent Development
    Table Sun Pharmaceutical Industries Company Details
    Table Sun Pharmaceutical Industries Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sun Pharmaceutical Industries Recent Development
    Table Livzon Pharmaceutical Company Details
    Table Livzon Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Livzon Pharmaceutical Recent Development
    Table Beijing Biote Pharmaceutical Company Details
    Table Beijing Biote Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Beijing Biote Pharmaceutical Recent Development
    Table Soho-YImIng Company Details
    Table Soho-YImIng Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Soho-YImIng Recent Development
    Table AbbVie Company Details
    Table AbbVie Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table AbbVie Recent Development
    Table Sanofi Company Details
    Table Sanofi Leuprolide Acetate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table Astellas Pharma Company Details
    Table Abbott Company Details
    Table Merck Company Details
    Table Pfizer Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Leuprolide Acetate Value Chain
    Table Typical Suppliers of Key Leuprolide Acetate Raw Material
    Table Leuprolide Acetate Customers List
    Table Leuprolide Acetate Sales Channels
    Table Leuprolide Acetate Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com